US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CRDF

Cardiff Oncology (CRDF)

Cardiff Oncology Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRDF

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
02/05/2024	15:05	GlobeNewswire Inc.	Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
25/04/2024	15:05	GlobeNewswire Inc.	Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
08/04/2024	15:05	GlobeNewswire Inc.	Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study	NASDAQ:CRDF	Cardiff Oncology Inc
07/03/2024	17:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRDF	Cardiff Oncology Inc
06/03/2024	15:05	GlobeNewswire Inc.	Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024	NASDAQ:CRDF	Cardiff Oncology Inc
29/02/2024	15:07	GlobeNewswire Inc.	Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
29/02/2024	15:06	GlobeNewswire Inc.	Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC	NASDAQ:CRDF	Cardiff Oncology Inc
29/02/2024	15:05	GlobeNewswire Inc.	Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)	NASDAQ:CRDF	Cardiff Oncology Inc
29/02/2024	15:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CRDF	Cardiff Oncology Inc
26/02/2024	07:00	GlobeNewswire Inc.	Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference	NASDAQ:CRDF	Cardiff Oncology Inc
22/02/2024	07:00	GlobeNewswire Inc.	Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
06/02/2024	15:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CRDF	Cardiff Oncology Inc
17/01/2024	09:30	PR Newswire (US)	Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research	NASDAQ:CRDF	Cardiff Oncology Inc
08/01/2024	08:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRDF	Cardiff Oncology Inc
20/11/2023	15:05	PR Newswire (US)	Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:CRDF	Cardiff Oncology Inc
02/11/2023	15:05	PR Newswire (US)	Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
02/11/2023	15:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRDF	Cardiff Oncology Inc
26/10/2023	15:05	PR Newswire (US)	Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
26/09/2023	15:05	PR Newswire (US)	Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy	NASDAQ:CRDF	Cardiff Oncology Inc
05/09/2023	07:00	PR Newswire (US)	Cardiff Oncology to Present at Upcoming Investor Conferences in September	NASDAQ:CRDF	Cardiff Oncology Inc
09/08/2023	15:05	PR Newswire (US)	Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
07/08/2023	15:05	PR Newswire (US)	Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship	NASDAQ:CRDF	Cardiff Oncology Inc
24/07/2023	16:09	PR Newswire (US)	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CRDF	Cardiff Oncology Inc
20/06/2023	16:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRDF	Cardiff Oncology Inc
20/06/2023	16:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRDF	Cardiff Oncology Inc
05/06/2023	07:00	PR Newswire (US)	Cardiff Oncology to Present at the Jefferies Healthcare Conference	NASDAQ:CRDF	Cardiff Oncology Inc
04/05/2023	15:10	PR Newswire (US)	Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update	NASDAQ:CRDF	Cardiff Oncology Inc
04/05/2023	15:01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CRDF	Cardiff Oncology Inc
27/04/2023	15:10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CRDF	Cardiff Oncology Inc
27/04/2023	15:09	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:CRDF	Cardiff Oncology Inc

Showing the most relevant articles for your search:NASDAQ:CRDF

1 2 3 4 5 6 7 Próxima >

Health Care Select Sector

Energy Select Sector SPDR

Euro vs US Dollar

BNP Paribas (QX)

Deutsche Telekom (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones